Niox Group (NIOX)

Sector:

Health Care

Index:

FTSE AIM 50

67.00p
   
  • Change Today:
      1.40p
  • 52 Week High: 76.00
  • 52 Week Low: 54.60
  • Currency: UK Pounds
  • Shares Issued: 399.36m
  • Volume: 1,840,834
  • Market Cap: £267.57m

Niox Group Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Key Personnel

CEO: Jonathan Emms
Chief Finance Officer: Michael R D Roller
Executive Chairman: Ian Johnson
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: Sharon Curran
Senior Independent Director: Garry Watts
Non-Executive Dir: Nicholas Mills, Robert (Rob) Graham Naylor

Contact Details

Address: Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom, OX4 4GB
Phone: +44 (0)1865 405560
Fax: +44 (0)7092 987560
Website: http://www.niox.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
Overseas Listings: BATSLON:CIRL
ISIN: GB00BJVD3B28

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Niox Group Market Data

Currency UK Pounds
Share Price 67.00p
Change Today 1.40p
% Change 2.13 %
52 Week High 76.00
52 Week Low 54.60
Volume 1,840,834
Shares Issued 399.36m
Market Cap £267.57m

Niox Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.85% below the market average71.85% below the market average71.85% below the market average71.85% below the market average71.85% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average
Price Trend
47.94% above the market average47.94% above the market average47.94% above the market average47.94% above the market average47.94% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average
Income
81.47% below the market average81.47% below the market average81.47% below the market average81.47% below the market average81.47% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
34.53% above the market average34.53% above the market average34.53% above the market average34.53% above the market average34.53% above the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Niox Group Dividends

  Latest Previous
  Final Final
Ex-Div 15-May-25 23-May-24
Paid 16-Jun-25 24-Jun-24
Amount 1.25p 1.00p

Trades for 09-May-2025

Time Volume / Share Price
16:38 102,164 @ 66.79p
16:38 183,108 @ 66.79p
15:55 118,429 @ 66.60p
16:38 33,998 @ 66.79p
16:36 3,500 @ 67.00p

Niox Group Key Personnel

CEO Jonathan Emms

Top of Page